Published on in Vol 3, No 1 (2020): Jan-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/20747, first published .
Effect of a Smartphone-Based App on the Quality of Life of Patients With Heart Failure: Randomized Controlled Trial

Effect of a Smartphone-Based App on the Quality of Life of Patients With Heart Failure: Randomized Controlled Trial

Effect of a Smartphone-Based App on the Quality of Life of Patients With Heart Failure: Randomized Controlled Trial

Journals

  1. Ferré-Grau C, Raigal-Aran L, Lorca-Cabrera J, Lluch-Canut T, Ferré-Bergadà M, Lleixá-Fortuño M, Puig-Llobet M, Miguel-Ruiz M, Albacar-Riobóo N. A Mobile App–Based Intervention Program for Nonprofessional Caregivers to Promote Positive Mental Health: Randomized Controlled Trial. JMIR mHealth and uHealth 2021;9(1):e21708 View
  2. Diaz-Skeete Y, McQuaid D, Akinosun A, Ekerete I, Carragher N, Carragher L. An Analysis of Apps with a Medication List Functionality for Older Adults with Heart Failure: Evaluation using the Mobile Application Rating Scale (MARS) and the IMS Institute for Healthcare Informatics Functionality Score (Preprint). JMIR mHealth and uHealth 2021 View
  3. Rezapour A, Tashakori-Miyanroudi M, Haghjoo M, Barzegar M, Tatarpour P, Souresrafil A, Gorji H, Yousefzadeh N, Sheikhy-Chaman M. Cost Effectiveness of Adding Dapagliflozin to Standard Care in Heart Failure Patients with Reduced Ejection Fraction: A Systematic Review. American Journal of Cardiovascular Drugs 2023;23(2):127 View

Books/Policy Documents

  1. Martín-Payo R, Pérez-González S, Menéndez-Pérez C, Martínez-Pinilla E, Fernández Álvarez M. La Universidad que Experimenta. View